Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

View source ↗

Summary

A recruiting clinical trial in Kazakhstan investigates epigenetic-based prevention for non-communicable diseases, with personalized approaches and biological ag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asfendiyarov Kazakh National Medical University | Conditions: Cardiovascular Diseases (CVD), Type 2 Diabetes | Status: RECRUITING